WEHI-345 analog
Product Specifications
UNSPSC Description
WEHI-345 analog is the analog of WEHI-345. WEHI-345 is a potent and selective RIPK2 kinase inhibitor with an IC50 of 0.13 μM, which delays RIPK2 ubiquitylation and NF-κB activation on oligomerization domain (NOD) stimulation[1].
Target Antigen
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/WEHI-345-analog.html
Purity
98.41
Solubility
DMSO : 30 mg/mL (ultrasonic;warming)
Smiles
O=C(C1=NC=CC=C1C)NCC(C)(N2N=C(C3=CC=C(C)C=C3)C4=C(N)N=CN=C42)C
Molecular Weight
415.49
References & Citations
[1]Nachbur U, et al. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production. Nat Commun. 2015 Mar 17;6:6442.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-100112/WEHI-345-analog-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-100112/WEHI-345-analog-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1354825-62-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
cAP-1299 1 Frozen Vial
CHO-K1/HEK293 Cells Stable expressing GPCR protein NPY4R (Protein accession # NM_005972)
Ask
View Details 